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Abstract
The sentinel node is the first lymph node that receives the lymph
drainage from the primary tumour. The pathological status of
the sentinel node should reflect the histopathology of the entire
regional lymph drainage area — both vulvar and cervical can-
cer spread through the lymphatic system. In gynaecological
oncology recent studies have confirmed the utility of the senti-
nel node concept in vulvar and cervical cancer.
Three techniques for sentinel node localisation are available.
The preoperative lymphoscintigraphy and intraoperative hand-
held gamma probe detection require the administration of the
technetium-99m-labelled colloid around the tumour. The other
method is based on the injection of the patent blue dye — dur-
ing the surgery of the sentinel node because of the dye uptake
becomes visible.
Following detection, the sentinel lymph node can be removed
separately and assessed with ultrastaging and immunohis-
tochemical staining. In the early stages of vulvar and cervical
cancer the lymph nodes metastases rate is relatively low — in
most cases lymphadenectomy is not necessary. The determi-
nation of the regional lymph nodes’ pathological status may
limit the extent of the surgical treatment.
The sentinel node detection rate is relatively high and depends
on the applied technique. This technique may play an impor-
tant role in the treatment of vulvar and cervical cancer.
This paper describes the details of sentinel node identification
and reviews the literature.
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Introduction
The sentinel lymph node concept was introduced in the year
1977 by Cabanas in his work on penile carcinoma [1]. The senti-
nel node is the first lymph node that receives the lymph drainage
from the primary tumour. The pathological status of the sentinel
node should reflect the histopathology of the entire regional lymph
drainage area [2–5] — both vulvar and cervical cancer spread
through the lymphatic system. For instance a negative result of
the histopathological examination of the sentinel node should pre-
dict the absence of the metastases in the remaining lymphatic
basin.
This idea has already been widely applied in surgical treat-
ment of breast cancer and malignant melanoma cases [2–6]. In
recent years in gynaecological oncology the results of preliminary
studies have confirmed the utility of the sentinel node concept in
vulvar and cervical cancer [2].
Three techniques for the sentinel node localisation are avail-
able [9, 12–15]. The preoperative lymphoscintigraphy and intra-
operative hand-held gamma probe detection require the admin-
istration of the radioisotope-labelled colloid around the tumour.
The last method is based on the injection of the patent blue dye
— during the surgery the sentinel node uptakes the dye and be-
comes visible.
The sentinel node detection rate is relatively high and depends
on the applied technique. This technique may play an important
role in the treatment of vulvar and cervical cancer.
Description of the method of radionuclide
sentinel node detection techniques
Usually, one day before the planned operation, a sulphur col-
loid or albumin colloid labelled with 99m Tc is administered (total
dose approximately 10–20 MBq depending on the tumour size).
In patients with vulvar cancer the tracer is injected intradermally
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around the tumour. In the case of cervical cancer four injections
are made, each within one quadrant of the cervix. After the tracer
administration lymphoscintigraphy is performed and the places
of increased radiocolloid absorption are marked on the patient’s
skin [9, 13, 14, 23].
During the surgery under general anaesthesia and after pre-
paring the access to the regional lymphatic tissue (determined by
the preoperative lymphoscintigraphy) approximately 2–4 ml of 1%
patent blue dye is injected analogically to the radiocolloid tracer
administration [9, 12, 15]. Finally the sentinel node localisation is
carried out with the hand-held gamma probe and is assisted with
the direct identification of the stained lymph nodes. The resected
sentinel node is sent for pathological examination.
After removal of the first sentinel node a gamma hand probe
is used to assess the remainder of the lymphatic basin. If there is
an elevated number of gamma counts in the second node it will
be sent for pathological evaluation as a second sentinel node.
The remaining regional lymph nodes are also taken off during the
following part of the operation [9, 13, 23].
In the pathology laboratory the sentinel nodes are examined
with routine staining (eosin and haematoxylin). If the nodes turn
out negative on the procedure the ultrastaging (step sectioning
with 400 mm interval) and cytokeratin staining can be used. The
remaining regional lymph nodes are evaluated using routine stain-
ing methods [9, 12].
Review of literature
Vulvar cancer
Vulvar cancer spreads predominantly through the lymphatic
system. Lymphadenectomy is an indispensable part of the surgi-
cal treatment. The resection of the lymph nodes has two aspects
— a therapeutic and a diagnostic one. Surgical treatment of vul-
var cancer is associated with a significant mortality rate (up to 2%
of cases) and a high percentage of postoperative complications,
such as delayed wound healing and lymphatic leg oedema [2, 7].
The incidence of lymph node metastases in vulvar cancer
depends on the clinical stage of the disease — in the early cases
it amounts to 20% [2, 8, 9]. In most patients with vulvar cancer,
surgical treatment is too radical. The possibility of the precise
determination of the pathological status of the inguinal lymph
nodes, including detection of micrometastases, could result in
limiting the extent of surgery.
The first results of intraoperative lymphatic mapping in pa-
tients with vulvar cancer were published in the year 1994 and 1995
by Levenback et al. [10, 11]. The sentinel node was found in 86%
of patients using the patent blue dye. Recent data of Levenback
et al. based on the material of 52 patients confirm the high rate of
sentinel node localisation with the blue dye (88% of patients, 75%
of dissected groins). The authors also defined the factors associ-
ated with the failure to identify the sentinel nodes — the type of
previous biopsy, the location of the tumour and the clinical expe-
rience of the surgeon [12].
Terada et al. applied lymphoscintigraphy together with patent
blue dye — the sentinel node was detected in all 9 patients with
vulvar cancer [13]. On pathological examination the use of the ul-
trastaging and cytokeratine staining revealed micrometastases in 2
of 14 lymph nodes negative on standard histopathological staining.
De Cicco et al. employed the intraoperative lymphoscintigra-
phy and managed to localise the sentinel node in all 37 patients
[14]. There was complete agreement between the results of the
pathological examination of the sentinel node and the regional
lymph nodes — in all 29 patients with negative sentinel nodes
there were no metastases in the remaining nodes.
In another study based on 59 patients (11 unilateral and 48
bilateral lymphadenectomies) de Hullu et al. report the sentinel
node detection in 95 of 107 operated groins [15]. Identification
mainly relied on intraoperative lymphoscintigraphy because patent
blue dye technique enabled the identification of only 60% of the
sentinel nodes. On pathological evaluation there were no false-
negative cases. With the use of step sectioning and the immu-
nochemical staining four metastatic sentinel nodes were found in
the group of 102 nodes negative on pathological examination.
In the recent data based on 26 cases of vulvar cancer report-
ed by Sliutz et al. preoperative lymphoscintigraphy showed focal
uptake in sentinel nodes in all 26 patients [9]. Intraoperatively in
20 cases one sentinel node was found unilaterally and in the other
6 patients two or more nodes were detected bilaterally. Histolog-
ically positive sentinel nodes were found in 9 cases with no false
negative findings.
Cervical cancer
In the case of patients with cervical cancer in the FIGO I and II
clinical stage (neoplasmatic process limited to uterus or expand-
ing to the parametrium and vagina – suitable for surgical treat-
ment) the incidence of metastatic disease in the lymph nodes
amounted respectively to 0–16% and 24–31% [17]. Like with vul-
var cancer, a prevalent group of patients has no benefit from rad-
ical lymphoadenectomy. The absence of metastases in a sentinel
node enables the avoidance of radical surgery and consequently
a potential reduction in morbidity.
The usefulness of this method is still being evaluated. The
lymphatic mapping procedure in cervical cancer encounters some
technical difficulties. The lymphatic drainage in cervical cancer is
much more complex than in vulvar cancer and it is unclear wheth-
er a cervical cancer may drain to several lymphatic nodes simul-
taneously. Additionally — except for small lesions located on the
exocervix — a precise injection of tracer around the tumour is
generally not possible [2, 18].
For those reasons the rate of sentinel node detection in cervi-
cal cancer is lower than in vulvar cancer.
One of the first reports regarding sentinel node identification
in cervical cancer was made by Verheijen et al. [4]. The authors
used three methods of detection (preoperative and intraoperative
lymphoscintigraphy, patent blue dye injection). The highest senti-
nel node detection rate (8 out of 10 patients) was obtained with
intraoperative lymphoscintigraphy.
O’Boyle et al., applying the patent blue dye method, conclud-
ed that the primary cervical tumour size is an important factor
positively influencing the detection rate [18]. In this study the sen-
tinel node was found in 60% of cases.
Another paper by Levenback et al. reports a high detection
rate (100%) in patients with cervical cancer, utilising a hand-held
intraoperative gamma probe [20]. In the same group of patients
preoperative lymphoscintigraphy detected at least one sentinel
node in 26 of 30 patients (87%)
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Some studies dealt with the evaluation of the sentinel node
techniques with the use of laparoscopy. D’Argent et al. managed
to find the sentinel node in 59 of 69 patients (85%) with patent
blue dye technique [21]. The failures were explained by an insuf-
ficient amount of the administered dye. Similar data presented by
Malur et al. found the sentinel node during laparoscopy in 78% of
cases, utilising intraoperative lymphoscintigraphy and patent blue
dye [22].
Discussion
The sentinel node concept is widely discussed in oncological
gynaecology.  A number of studies on that issue have been pub-
lished, but still there are no standards of sentinel node detection
[15, 21–24]. There is a need to confirm the presumptions about
the sentinel node concept — verifying the relation between the
presence of the metastases in the sentinel node and the remain-
ing regional lymph nodes. All authors stress the necessity of open-
ing multi-centre, randomised studies concerning the use of the
sentinel node detection technique.
Before introducing the procedure into routine treatment, sev-
eral other problems must  be solved first, such as unifying the
techniques, verifying the sensitivity of the method, identifying prob-
able modifying factors and precise determination of the lymphatic
flow in both cervical and vulvar cancer.
The results of the studies published so far indicate that the
most effective technique for the sentinel node localisation is intra-
operative gamma probe node detection assisted by blue dye ad-
ministration. The preoperative lymphoscintigraphy did not improve
the sentinel node detection rate and had significantly complicat-
ed the whole procedure [19, 20]. On the other hand in the cases
of vulvar cancer, the preoperative lymphoscintigraphy allowed
a determination of the lateralisation of the lymph flow.
There is a decreased probability of sentinel node detection in
patients who were treated with chemotherapy or radiotherapy pri-
or to surgical treatment, who underwent an operation involving
the lymphatic basin prior to the oncological treatment or in pa-
tients with macroscopic changes in the regional lymph nodes.
There was an impaired radiotracer and dye penetration including
the cancer-related occlusion of the cervical stromal lymphatic sys-
tem [2, 12, 18]. Other possible reasons were: excessive vaginal
or peritoneal spillage or disruption of the lymphatic channels dur-
ing initial dissection.
An important problem affecting the validation of the lymphatic
mapping concept in vulvar cancer is the low morbidity of this dis-
ease. Therefore, obtaining data from prospective randomised tri-
als will be difficult.
The authors are not familiar with any reports concerning ad-
verse events due to radiocolloid administration. The applied
amount of the Tc99m — labelled colloid does not exceed the radi-
ation safety standards — including the patient, surgical team and
hospital staff [2, 14]. A severe anaphylactic reaction after the patent
blue dye administration is possible but very rare [2].
Another complication of the procedure is a pulse oximetry
desaturation observed shortly after the dye injection. This event is
attributed to the dye properties to absorb the wavelengths used
to measure the oxygen saturation. The arterial blood gas determi-
nation confirms the patient’s condition.
Conclusions
1. Sentinel node detection, frequently applied in the surgical treat-
ment of breast cancer and malignant melanoma, seems to
have a potential value in gynaecological oncology for lymphatic
mapping in vulvar cancer and cervical cancer.
2. Lymphoscintigraphy has a higher sentinel node detection rate
than blue dye injection, but the best results have been achieved
using these two methods together.
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